PL2698372T3 - Nowy związek imidazooksazynowy lub jego sól - Google Patents
Nowy związek imidazooksazynowy lub jego sólInfo
- Publication number
- PL2698372T3 PL2698372T3 PL12768337T PL12768337T PL2698372T3 PL 2698372 T3 PL2698372 T3 PL 2698372T3 PL 12768337 T PL12768337 T PL 12768337T PL 12768337 T PL12768337 T PL 12768337T PL 2698372 T3 PL2698372 T3 PL 2698372T3
- Authority
- PL
- Poland
- Prior art keywords
- salt
- oxazine compound
- novel imidazo
- imidazo
- novel
- Prior art date
Links
- -1 imidazo-oxazine compound Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011084880 | 2011-04-06 | ||
| EP12768337.3A EP2698372B1 (en) | 2011-04-06 | 2012-04-05 | Novel imidazo-oxazine compound or salt thereof |
| PCT/JP2012/059376 WO2012137870A1 (ja) | 2011-04-06 | 2012-04-05 | 新規イミダゾオキサジン化合物又はその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2698372T3 true PL2698372T3 (pl) | 2016-07-29 |
Family
ID=46969260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12768337T PL2698372T3 (pl) | 2011-04-06 | 2012-04-05 | Nowy związek imidazooksazynowy lub jego sól |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8772283B2 (pl) |
| EP (1) | EP2698372B1 (pl) |
| JP (1) | JP5599941B2 (pl) |
| KR (1) | KR101658274B1 (pl) |
| CN (1) | CN103459400B (pl) |
| AU (1) | AU2012239157B2 (pl) |
| BR (1) | BR112013025732B1 (pl) |
| CA (1) | CA2830367C (pl) |
| DK (1) | DK2698372T3 (pl) |
| ES (1) | ES2567605T3 (pl) |
| HU (1) | HUE027509T2 (pl) |
| MX (1) | MX342064B (pl) |
| MY (1) | MY163187A (pl) |
| PH (1) | PH12013501873A1 (pl) |
| PL (1) | PL2698372T3 (pl) |
| RU (1) | RU2578608C2 (pl) |
| SG (1) | SG193327A1 (pl) |
| TW (1) | TWI525097B (pl) |
| WO (1) | WO2012137870A1 (pl) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014007217A1 (ja) * | 2012-07-02 | 2014-01-09 | 大鵬薬品工業株式会社 | イミダゾオキサジン化合物による抗腫瘍効果増強剤 |
| WO2014158647A1 (en) * | 2013-03-13 | 2014-10-02 | Dow Agrosciences Llc | Preparation of triaryl rhamnose carbamates |
| JP6289459B2 (ja) * | 2013-06-20 | 2018-03-07 | 大鵬薬品工業株式会社 | ＰＨＬＤＡ１又はＰＩＫ３Ｃ２Ｂの発現に基づくＰＩ３Ｋ／ＡＫＴ／ｍＴＯＲ阻害剤の治療効果の予測方法 |
| JP6084292B2 (ja) | 2013-07-18 | 2017-02-22 | 大鵬薬品工業株式会社 | Ｆｇｆｒ阻害剤耐性癌の治療薬 |
| DK3023100T3 (da) | 2013-07-18 | 2019-05-27 | Taiho Pharmaceutical Co Ltd | Antitumorlægemiddel til intermitterende administration af fgfr-hæmmer |
| CN107428779A (zh) * | 2015-02-27 | 2017-12-01 | 大鹏药品工业株式会社 | 咪唑并噁嗪晶体、含有所述晶体的药物组合物和制备所述晶体的方法 |
| US10434103B2 (en) | 2015-03-31 | 2019-10-08 | Taiho Pharmaceutical Co., Ltd. | Crystal of 3,5-disubstituted benzene alkynyl compound |
| KR20250007056A (ko) | 2016-03-04 | 2025-01-13 | 다이호야쿠힌고교 가부시키가이샤 | 악성 종양 치료용 제제 및 조성물 |
| US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
| US11833151B2 (en) | 2018-03-19 | 2023-12-05 | Taiho Pharmaceutical Co., Ltd. | Pharmaceutical composition including sodium alkyl sulfate |
| WO2020078865A1 (en) | 2018-10-16 | 2020-04-23 | F. Hoffmann-La Roche Ag | Use of akt inhibitors in ophthalmology |
| JP7574184B2 (ja) * | 2019-06-21 | 2024-10-28 | 大鵬薬品工業株式会社 | 悪性腫瘍の治療方法 |
| US20220402916A1 (en) | 2019-09-18 | 2022-12-22 | Merck Sharp & Dohme Corp. | Small molecule inhibitors of kras g12c mutant |
| MD4051678T2 (en) | 2019-10-28 | 2026-07-31 | Merck Sharp & Dohme Llc | Small molecule inhibitors of the KRAS G12C mutant |
| WO2021085653A1 (en) | 2019-10-31 | 2021-05-06 | Taiho Pharmaceutical Co., Ltd. | 4-aminobut-2-enamide derivatives and salts thereof |
| WO2021106231A1 (en) | 2019-11-29 | 2021-06-03 | Taiho Pharmaceutical Co., Ltd. | A compound having inhibitory activity against kras g12d mutation |
| WO2021215544A1 (en) | 2020-04-24 | 2021-10-28 | Taiho Pharmaceutical Co., Ltd. | Kras g12d protein inhibitors |
| US12702658B2 (en) | 2020-04-24 | 2026-08-11 | Taiho Pharmaceutical Co., Ltd. | Anticancer combination therapy with N-(1-acryloyl-azetidin-3-yl)-2-((1H-indazol-3-yl)amino)methyl)-1H-imidazole-5-carboxamide inhibitor of KRAS-G12C |
| TW202216151A (zh) | 2020-07-15 | 2022-05-01 | 日商大鵬藥品工業股份有限公司 | 含有使用於腫瘤之治療之嘧啶化合物之組合 |
| WO2022165056A1 (en) * | 2021-02-01 | 2022-08-04 | Taiho Pharmaceutical Co., Ltd. | Treating cancer in patient with pten inactivating mutation |
| CN117769554A (zh) | 2021-05-28 | 2024-03-26 | 大鹏药品工业株式会社 | Kras突变蛋白的小分子抑制剂 |
| KR20260042550A (ko) | 2023-08-24 | 2026-03-31 | 다이호야쿠힌고교 가부시키가이샤 | 세다주리딘 및 아자시티딘의 고정 용량 조합물 |
| US11970475B1 (en) | 2023-09-05 | 2024-04-30 | King Faisal University | 4-(1-(2-Hydroxypropyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-3-ol as an antimicrobial compound |
| KR20260096846A (ko) | 2023-10-20 | 2026-06-24 | 머크 샤프 앤드 돔 엘엘씨 | Kras 단백질의 소분자 억제제 |
| WO2025128834A1 (en) * | 2023-12-15 | 2025-06-19 | Alterome Therapeutics, Inc. | Akt1 modulators |
| WO2026161671A1 (en) | 2025-01-23 | 2026-07-30 | Merck Sharp & Dohme Llc | Small molecule inhibitors of kras proteins |
| CN119912475B (zh) * | 2025-03-06 | 2026-01-06 | 复旦大学 | 用作tlr2拮抗剂的化合物或其衍生物及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57212188A (en) | 1981-06-25 | 1982-12-27 | Sankyo Co Ltd | Imidazobenzoxazine derivative and its preparation |
| US5985871A (en) * | 1997-12-24 | 1999-11-16 | Cortex Pharmaceuticals, Inc. | Benzoxazine compounds for enhancing synaptic response |
| CA2561311A1 (en) * | 2004-04-09 | 2005-10-27 | Merck & Co., Inc. | Inhibitors of akt activity |
| AR064010A1 (es) | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| CA2695251C (en) * | 2007-08-14 | 2016-06-21 | Bayer Schering Pharma Aktiengesellschaft | Fused imidazoles for cancer treatment |
| US9451809B2 (en) | 2008-05-29 | 2016-09-27 | Nike, Inc. | Article of footwear with a marking system |
| US8207169B2 (en) * | 2008-06-03 | 2012-06-26 | Msd K.K. | Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D |
| WO2010088177A1 (en) | 2009-02-02 | 2010-08-05 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| EP2406250B1 (en) | 2009-03-11 | 2015-08-12 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| EP2413932A4 (en) | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | HAMMER OF ACT ACTIVITY |
| CA2804845A1 (en) * | 2010-07-12 | 2012-01-19 | Stuart Ince | Substituted imidazo[1,2-a]pyrimidines and -pyridines |
-
2012
- 2012-04-05 CN CN201280017414.4A patent/CN103459400B/zh active Active
- 2012-04-05 DK DK12768337.3T patent/DK2698372T3/en active
- 2012-04-05 HU HUE12768337A patent/HUE027509T2/en unknown
- 2012-04-05 PL PL12768337T patent/PL2698372T3/pl unknown
- 2012-04-05 EP EP12768337.3A patent/EP2698372B1/en active Active
- 2012-04-05 ES ES12768337.3T patent/ES2567605T3/es active Active
- 2012-04-05 AU AU2012239157A patent/AU2012239157B2/en active Active
- 2012-04-05 CA CA2830367A patent/CA2830367C/en active Active
- 2012-04-05 SG SG2013066949A patent/SG193327A1/en unknown
- 2012-04-05 RU RU2013149174/04A patent/RU2578608C2/ru active
- 2012-04-05 PH PH1/2013/501873A patent/PH12013501873A1/en unknown
- 2012-04-05 BR BR112013025732-6A patent/BR112013025732B1/pt active IP Right Grant
- 2012-04-05 MX MX2013011429A patent/MX342064B/es active IP Right Grant
- 2012-04-05 KR KR1020137029041A patent/KR101658274B1/ko active Active
- 2012-04-05 TW TW101112057A patent/TWI525097B/zh active
- 2012-04-05 US US14/004,446 patent/US8772283B2/en active Active
- 2012-04-05 MY MYPI2013701632A patent/MY163187A/en unknown
- 2012-04-05 WO PCT/JP2012/059376 patent/WO2012137870A1/ja not_active Ceased
- 2012-04-05 JP JP2013508918A patent/JP5599941B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2698372B1 (en) | 2016-02-03 |
| AU2012239157A1 (en) | 2013-09-26 |
| EP2698372A1 (en) | 2014-02-19 |
| ES2567605T3 (es) | 2016-04-25 |
| CN103459400A (zh) | 2013-12-18 |
| KR101658274B1 (ko) | 2016-09-22 |
| US20140005185A1 (en) | 2014-01-02 |
| RU2013149174A (ru) | 2015-05-20 |
| MX2013011429A (es) | 2013-12-09 |
| KR20140039186A (ko) | 2014-04-01 |
| MY163187A (en) | 2017-08-15 |
| MX342064B (es) | 2016-09-12 |
| BR112013025732B1 (pt) | 2022-02-22 |
| CA2830367C (en) | 2016-08-30 |
| JP5599941B2 (ja) | 2014-10-01 |
| PH12013501873A1 (en) | 2013-10-14 |
| US8772283B2 (en) | 2014-07-08 |
| TWI525097B (zh) | 2016-03-11 |
| AU2012239157B2 (en) | 2015-11-05 |
| CA2830367A1 (en) | 2012-10-11 |
| BR112013025732A2 (pt) | 2016-12-13 |
| RU2578608C2 (ru) | 2016-03-27 |
| HUE027509T2 (en) | 2016-10-28 |
| SG193327A1 (en) | 2013-10-30 |
| JPWO2012137870A1 (ja) | 2014-07-28 |
| CN103459400B (zh) | 2016-05-18 |
| TW201247679A (en) | 2012-12-01 |
| WO2012137870A1 (ja) | 2012-10-11 |
| HK1188451A1 (zh) | 2014-05-02 |
| DK2698372T3 (en) | 2016-03-21 |
| EP2698372A4 (en) | 2014-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286152A (en) | Modified imidazopyridinyl-aminopyridine compounds | |
| ZA201401268B (en) | Noribogaine salt ansolvates | |
| ZA201401553B (en) | Cyclopropaneamine compound | |
| GB201106799D0 (en) | Novel compounds | |
| GB201107325D0 (en) | Novel compounds | |
| GB201112607D0 (en) | Novel compounds | |
| SG11201405318PA (en) | Novel piperidine compound or salt thereof | |
| SG11201402876UA (en) | Quinolylpyrrolopyrimidyl fused-ring compound or salt thereof | |
| EP2717694A4 (en) | NEW COMPOUNDS | |
| GB201111704D0 (en) | Novel compounds | |
| EP2708540A4 (en) | PYRIMIDO-DIAZEPINONE COMPOUND | |
| PL2609093T3 (pl) | Związek soli | |
| GB201122305D0 (en) | Novel compound | |
| GB201112987D0 (en) | Novel compound | |
| GB201104669D0 (en) | Compound | |
| GB201121538D0 (en) | Compound | |
| GB201118102D0 (en) | Compound | |
| GB201101640D0 (en) | Novel compounds | |
| GB201111409D0 (en) | Novel compounds | |
| GB201113761D0 (en) | Novel compounds | |
| GB201111476D0 (en) | Novel compounds | |
| GB201111229D0 (en) | Novel compounds | |
| GB201121358D0 (en) | Novel compounds | |
| GB201111410D0 (en) | Novel compounds | |
| GB201111308D0 (en) | Novel compounds |